Hasil Pencarian - Gianfranco Di Genova
- Menampilkan 1 - 2 hasil dari 2
-
1
-
2
The MEK inhibitor selumetinib complements CTLA-4 blockade by reprogramming the tumor immune microenvironment oleh Edmund Poon, Stefanie Mullins, Amanda Watkins, Geoffrey S. Williams, Jens-Oliver Koopmann, Gianfranco Di Genova, Marie Cumberbatch, Margaret Veldman-Jones, Shaun E. Grosskurth, Vasu Sah, Alwin Schuller, Corrine Reimer, Simon J. Dovedi, Paul D. Smith, Ross Stewart, Robert W. Wilkinson
Diterbitkan 2017-08-01
Artikel